ArticlePharmacoEconomics2010
Cost effectiveness of etoricoxib versus celecoxib and non-selective NSAIDS in the treatment of ankylosing spondylitis.
Jeroen P Jansen et al.PubMed ↗Publisher ↗
No numbers read from the abstract.
7 papers cite it
this paperpooled itcites it